Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities of continuing operations:
Net (loss)	$ (847,385)	$ (4,942,113)
Net income (loss) attributable to non-controlling interest	(13,320)	3,387
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	2,106	4,597
Gain on the extinguishment of debt	(34,373)	0
Stock-based compensation	5,170	3,765,591
Change in the fair market value of derivative liability	73,398	(0)
Issuance of financing commitment shares	75,584	0
Issuance of financing commitment warrants	100,667	0
Beneficial conversion feature of Preferred C Stock	0	795,131
Changes in operating assets and liabilities:
Other assets	0	(110)
Accounts receivable	(570)	(7,139)
Account receivable-other	(747)	(43,603)
Inventory	(9,089)	(1,219)
Accounts payable	33,731	(12,099)
Accrued liabilities	35,688	(14,014)
Net cash used in operating activities	(579,140)	(451,591)
Cash flows used in investing activities:
Purchase of fixed assets	(40,852)	(1,910)
Net cash used in financing activities	(40,852)	(1,910)
Cash flows from financing activities:
Proceeds from convertible notes - net of conversions	550,000	0
Proceeds from notes payable	250,000	0
Proceeds from the sale of common stock	0	435,650
Proceeds from the sale of preferred stock	5,000	120,000
Net cash provided by financing activities	805,000	555,650
Net increase in cash and cash equivalents	185,008	102,149
Cash and cash equivalents at beginning of period	139,485	37,336
Cash and cash equivalents at end of period	324,493	139,485
Supplemental disclosure of cash flow information:
Cash paid for interest	0	0
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities
Conversion of convertible notes and accrued interest into common stock	$ 58,027	$ 0